pubmed-article:21482022 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:21482022 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
pubmed-article:21482022 | lifeskim:mentions | umls-concept:C0376358 | lld:lifeskim |
pubmed-article:21482022 | lifeskim:mentions | umls-concept:C0138741 | lld:lifeskim |
pubmed-article:21482022 | lifeskim:mentions | umls-concept:C0033572 | lld:lifeskim |
pubmed-article:21482022 | lifeskim:mentions | umls-concept:C0005558 | lld:lifeskim |
pubmed-article:21482022 | lifeskim:mentions | umls-concept:C0597298 | lld:lifeskim |
pubmed-article:21482022 | lifeskim:mentions | umls-concept:C0332161 | lld:lifeskim |
pubmed-article:21482022 | lifeskim:mentions | umls-concept:C0542559 | lld:lifeskim |
pubmed-article:21482022 | lifeskim:mentions | umls-concept:C1274040 | lld:lifeskim |
pubmed-article:21482022 | lifeskim:mentions | umls-concept:C0439810 | lld:lifeskim |
pubmed-article:21482022 | lifeskim:mentions | umls-concept:C0681842 | lld:lifeskim |
pubmed-article:21482022 | lifeskim:mentions | umls-concept:C0033522 | lld:lifeskim |
pubmed-article:21482022 | lifeskim:mentions | umls-concept:C0205210 | lld:lifeskim |
pubmed-article:21482022 | lifeskim:mentions | umls-concept:C0205265 | lld:lifeskim |
pubmed-article:21482022 | lifeskim:mentions | umls-concept:C0439275 | lld:lifeskim |
pubmed-article:21482022 | lifeskim:mentions | umls-concept:C1555582 | lld:lifeskim |
pubmed-article:21482022 | lifeskim:mentions | umls-concept:C0231449 | lld:lifeskim |
pubmed-article:21482022 | pubmed:issue | 2 | lld:pubmed |
pubmed-article:21482022 | pubmed:dateCreated | 2011-6-27 | lld:pubmed |
pubmed-article:21482022 | pubmed:abstractText | Total prostate-specific antigen (tPSA), ratio of free PSA (fPSA) to tPSA (%fPSA), and PSA density (PSAD) testing have a very low accuracy in the detection of prostate cancer (PCa). There is an urgent need for more accurate biomarkers. | lld:pubmed |
pubmed-article:21482022 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21482022 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21482022 | pubmed:language | eng | lld:pubmed |
pubmed-article:21482022 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21482022 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:21482022 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21482022 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:21482022 | pubmed:month | Aug | lld:pubmed |
pubmed-article:21482022 | pubmed:issn | 1873-7560 | lld:pubmed |
pubmed-article:21482022 | pubmed:author | pubmed-author:LazzeriMassim... | lld:pubmed |
pubmed-article:21482022 | pubmed:author | pubmed-author:GuazzoniGiorg... | lld:pubmed |
pubmed-article:21482022 | pubmed:author | pubmed-author:CeriottiFerru... | lld:pubmed |
pubmed-article:21482022 | pubmed:author | pubmed-author:RigattiPatriz... | lld:pubmed |
pubmed-article:21482022 | pubmed:author | pubmed-author:ScattoniVince... | lld:pubmed |
pubmed-article:21482022 | pubmed:author | pubmed-author:MontorsiFranc... | lld:pubmed |
pubmed-article:21482022 | pubmed:author | pubmed-author:NavaLucianoL | lld:pubmed |
pubmed-article:21482022 | pubmed:author | pubmed-author:FreschiMassim... | lld:pubmed |
pubmed-article:21482022 | pubmed:author | pubmed-author:BiniVittorioV | lld:pubmed |
pubmed-article:21482022 | pubmed:author | pubmed-author:DorigattiFern... | lld:pubmed |
pubmed-article:21482022 | pubmed:author | pubmed-author:PontilloMarin... | lld:pubmed |
pubmed-article:21482022 | pubmed:author | pubmed-author:MaccagnanoCar... | lld:pubmed |
pubmed-article:21482022 | pubmed:author | pubmed-author:LughezzaniGio... | lld:pubmed |
pubmed-article:21482022 | pubmed:copyrightInfo | Copyright © 2011 European Association of Urology. Published by Elsevier B.V. All rights reserved. | lld:pubmed |
pubmed-article:21482022 | pubmed:issnType | Electronic | lld:pubmed |
pubmed-article:21482022 | pubmed:volume | 60 | lld:pubmed |
pubmed-article:21482022 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:21482022 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:21482022 | pubmed:pagination | 214-22 | lld:pubmed |
pubmed-article:21482022 | pubmed:meshHeading | pubmed-meshheading:21482022... | lld:pubmed |
pubmed-article:21482022 | pubmed:meshHeading | pubmed-meshheading:21482022... | lld:pubmed |
pubmed-article:21482022 | pubmed:meshHeading | pubmed-meshheading:21482022... | lld:pubmed |
pubmed-article:21482022 | pubmed:meshHeading | pubmed-meshheading:21482022... | lld:pubmed |
pubmed-article:21482022 | pubmed:meshHeading | pubmed-meshheading:21482022... | lld:pubmed |
pubmed-article:21482022 | pubmed:meshHeading | pubmed-meshheading:21482022... | lld:pubmed |
pubmed-article:21482022 | pubmed:meshHeading | pubmed-meshheading:21482022... | lld:pubmed |
pubmed-article:21482022 | pubmed:meshHeading | pubmed-meshheading:21482022... | lld:pubmed |
pubmed-article:21482022 | pubmed:meshHeading | pubmed-meshheading:21482022... | lld:pubmed |
pubmed-article:21482022 | pubmed:meshHeading | pubmed-meshheading:21482022... | lld:pubmed |
pubmed-article:21482022 | pubmed:meshHeading | pubmed-meshheading:21482022... | lld:pubmed |
pubmed-article:21482022 | pubmed:meshHeading | pubmed-meshheading:21482022... | lld:pubmed |
pubmed-article:21482022 | pubmed:meshHeading | pubmed-meshheading:21482022... | lld:pubmed |
pubmed-article:21482022 | pubmed:meshHeading | pubmed-meshheading:21482022... | lld:pubmed |
pubmed-article:21482022 | pubmed:meshHeading | pubmed-meshheading:21482022... | lld:pubmed |
pubmed-article:21482022 | pubmed:meshHeading | pubmed-meshheading:21482022... | lld:pubmed |
pubmed-article:21482022 | pubmed:meshHeading | pubmed-meshheading:21482022... | lld:pubmed |
pubmed-article:21482022 | pubmed:meshHeading | pubmed-meshheading:21482022... | lld:pubmed |
pubmed-article:21482022 | pubmed:year | 2011 | lld:pubmed |
pubmed-article:21482022 | pubmed:articleTitle | Prostate-specific antigen (PSA) isoform p2PSA significantly improves the prediction of prostate cancer at initial extended prostate biopsies in patients with total PSA between 2.0 and 10 ng/ml: results of a prospective study in a clinical setting. | lld:pubmed |
pubmed-article:21482022 | pubmed:affiliation | Department of Urology, San Raffaele Turro, Vita-Salute San Raffaele University, Milan, Italy. | lld:pubmed |
pubmed-article:21482022 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:21482022 | pubmed:publicationType | Comparative Study | lld:pubmed |
pubmed-article:21482022 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
entrez-gene:354 | entrezgene:pubmed | pubmed-article:21482022 | lld:entrezgene |
http://linkedlifedata.com/r... | entrezgene:pubmed | pubmed-article:21482022 | lld:entrezgene |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:21482022 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:21482022 | lld:pubmed |